Asensus Surgical (ASXC) Stock Price, News & Analysis

Company Overview

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.

Key Stats

• Today's Range: $0.35 to $0.35
• 50-Day Range: N/A
• 52-Week Range: $0.17 to $0.40
• Volume: N/A
• Average Volume: 2.03 million shs
• Market Capitalization: $94.74 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $0.35
• Consensus Rating: Hold

ASXC Stock Analysis - Frequently Asked Questions

How have ASXC shares performed this year?

Asensus Surgical's stock was trading at $0.2466 at the beginning of 2024. Since then, ASXC shares have increased by 41.1% and is now trading at $0.3479.
View the best growth stocks for 2024 here.

How were Asensus Surgical's earnings last quarter?

Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) posted its quarterly earnings data on Wednesday, November, 3rd. The company reported ($0.07) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.01. The company had revenue of $2.57 million for the quarter, compared to the consensus estimate of $1.02 million. Asensus Surgical had a negative trailing twelve-month return on equity of 184.10% and a negative net margin of 902.25%.

How do I buy shares of Asensus Surgical?

Shares of ASXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Asensus Surgical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Asensus Surgical investors own include Block (SQ), Digital Turbine (APPS), CrowdStrike (CRWD), ChargePoint (CHPT), SoFi Technologies (SOFI) and Tesla (TSLA).

Company Calendar

• Last Earnings: 11/03/2021
• Today: 12/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NYSEAMERICAN:ASXC
• CUSIP: N/A
• CIK: N/A
• Web: www.asensus.com
• Phone: (919) 765-8400
• Fax: 919-765-8459
• Employees: 170
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $0.35
• High Stock Price Target: $0.35
• Low Stock Price Target: $0.35
• Potential Upside/Downside: +0.6%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.31)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-78,430,000.00
• Net Margins: -902.25%
• Pretax Margin: -899.16%
• Return on Equity: -184.10%
• Return on Assets: -114.75%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.00
• Quick Ratio: 0.69

Sales & Book Value

• Annual Sales: $8.58 million
• Price / Sales: 11.04
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.13 per share
• Price / Book: 2.68

Miscellaneous

• Outstanding Shares: 272,330,000
• Free Float: 264,516,000
• Market Cap: $94.74 million
• Optionable: Not Optionable
• Beta: 1.37